Exclusive: Trump admin shutting key US researchers out of global virus response talks, documents and sources reveal

Exclusive: Trump Admin Limits US Researchers’ Role in Global Virus Talks

Exclusive – Under the Trump administration, key U.S. researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have been excluded from critical international discussions on virus outbreaks, as revealed by internal documents and multiple sources. This strategy, which became prominent during the hantavirus crisis, has reportedly curtailed American scientists’ direct involvement in shaping global health responses. The move has drawn criticism from health experts, who argue it undermines the U.S.’s ability to lead in pandemic preparedness.

Restricted Communication and Virtual Participation

Exclusive – The Trump administration’s decision to limit NIAID staff’s interaction with the World Health Organization (WHO) was initially strict, but recent changes have allowed limited virtual engagement. A May 18 email from a senior NIAID official to staff, obtained by CNN, outlines the new approach, stating that participants are restricted to small groups of no more than three experts and are limited to a “listening role.” The same protocol is being applied to future outbreaks, including Ebola, as the administration continues to centralize decision-making.

“We’ll be operating in the same manner for Ebola as we have been doing for Hantavirus, assembling a small group of experts—no more than three—to participate.”

Exclusive – This shift in communication strategy has raised concerns about the effectiveness of U.S. responses to global health threats. The WHO, which plays a pivotal role in coordinating international efforts, has traditionally relied on open dialogue with U.S. experts to share insights and strategies. The current restrictions, however, have created a barrier to real-time collaboration, potentially slowing the dissemination of critical information during outbreaks. Insiders have called the situation “unheard of,” noting the disconnect between American scientific expertise and international decision-making.

Leadership Vacuums and Global Health Disengagement

Exclusive – Beyond communication limits, the Trump administration has faced criticism for its broader withdrawal from global health initiatives. In January, the U.S. officially withdrew from the WHO, a move that sparked backlash from public health professionals. This decision, coupled with prolonged leadership vacancies at the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and the Office of the Surgeon General, has left key agencies understaffed and less influential in global health discussions. The lack of permanent leadership has been described as unprecedented in scale.

Exclusive – The hantavirus outbreak highlighted these challenges, as the administration dispatched Brian Christine, the assistant secretary for health, to Nebraska to manage the crisis. Christine, known for his work on penile implants and right-leaning statements, was chosen despite not being the primary authority on hantavirus, underscoring the administrative turmoil within the response. A source familiar with the process explained that Christine was sent due to the unavailability of senior officials, further emphasizing the impact of leadership gaps on international engagement.

Exclusive – With the FDA commissioner recently stepping down and the surgeon general role still unfilled, the administration’s ability to coordinate a unified response to health emergencies has been questioned. The delays in appointing permanent leaders have affected the consistency of messaging and the effectiveness of policy implementation, raising concerns about the nation’s preparedness for future outbreaks. These vacancies, combined with the exclusion of key researchers from global dialogues, have left the U.S. at a disadvantage in international health leadership.